AI & Analytics

Emerging pharma: Why digital platforms level the field

Oct. 7, 2021 | Webinar | 30-minute watch

Emerging pharma: Why digital platforms level the field

Life sciences is heading toward a platform approach. According to Gartner, digital life science platforms are on track to be mainstream within five to 10 years.


For emerging pharmaceutical companies, platforms offer a distinct opportunity to reach customers without spending years building digital capabilities. Instead, prebuilt, out-of-the-box industry tools can jump-start the ability to deliver customers the experiences they expect.


Watch this webinar if you are a leader building commercial or analytics capabilities in the areas of biotech, oncology or cell and gene therapy.

  • Hear why you have a distinct opportunity to leverage platforms to compete in today’s dynamic healthcare ecosystem.
  • Understand what platforms do to help strengthen or build analytics and commercial operations.  
  • Learn how our platform, ZAIDYN™, brings together customer engagement, field performance and business analytics to help companies at all stages of maturity. 

Add insights to your inbox

We’ll send you content you’ll want to read – and put to use.

About the author(s)